Literature DB >> 8050181

T cell receptor repertoire and mitotic responses of lamina propria T lymphocytes in inflammatory bowel disease.

L Qiao1, M Golling, F Autschbach, G Schürmann, S C Meuer.   

Abstract

Human intestinal lamina propria T lymphocytes (LPL-T) physiologically exhibit minimal proliferation in response to antigen receptor stimulation in vitro. This is thought to occur as a consequence of regulatory influences which are exerted by the mucosal microenvironment. The present study is aimed at investigating whether proliferative responses of intestinal LPL-T to antigen receptor stimulation are altered in patients with inflammatory bowel disease. Accordingly, proliferative responses of LPL-T in patients with Crohn's disease and ulcerative colitis to stimulation with CD3 MoAb plus IL-2 were examined and compared with controls. In addition, T cell receptor (TCR) repertoires of LPL-T and peripheral blood T lymphocytes were determined by indirect immunofluorescence using a panel of 11 TCR V beta specific antibodies. In most patients with inflammatory bowel disease, LPL-T showed enhanced proliferation to antigen receptor stimulation compared with controls. Moreover, perhaps as a consequence, an enhanced frequency of in vivo preactivated T cells was seen as judged from an increased spontaneous proliferative response to low concentrations of exogenous IL-2. LPL-T and peripheral blood T lymphocytes exhibited similar percentages of TCR V beta gene usage both in controls and in patients. In summary, polyclonal activation of LPL-T due to impairment of local adjustment, i.e. insufficient down-regulation of TCR/CD3-dependent signalling processes, may contribute to the pathogenesis of inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050181      PMCID: PMC1534683          DOI: 10.1111/j.1365-2249.1994.tb06085.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

Review 2.  T cell recognition as the target for immune intervention in autoimmune disease.

Authors:  D C Wraith; H O McDevitt; L Steinman; H Acha-Orbea
Journal:  Cell       Date:  1989-06-02       Impact factor: 41.582

3.  T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis.

Authors:  J R Oksenberg; M Sherritt; A B Begovich; H A Erlich; C C Bernard; L L Cavalli-Sforza; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to T cell proliferation.

Authors:  S C Meuer; K H Meyer zum Büschenfelde
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

5.  Polyclonal nature of the intestinal mucosal lymphocyte populations in inflammatory bowel disease. A molecular genetic evaluation of the immunoglobulin and T-cell antigen receptors.

Authors:  W Kaulfersch; C Fiocchi; T A Waldmann
Journal:  Gastroenterology       Date:  1988-08       Impact factor: 22.682

6.  Immunoregulatory function of lamina propria T cells in Crohn's disease.

Authors:  S P James; C Fiocchi; A S Graeff; W Strober
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

7.  Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

Authors:  Y R Mahida; S Patel; K Wu; D P Jewell
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  Isolation and functional characterization of human intestinal mucosal lymphoid cells.

Authors:  D M Bull; M A Bookman
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.

Authors:  C Fiocchi; M L Hilfiker; K R Youngman; N C Doerder; J H Finke
Journal:  Gastroenterology       Date:  1984-04       Impact factor: 22.682

10.  An index of inflammatory activity in patients with Crohn's disease.

Authors:  P A van Hees; P H van Elteren; H J van Lier; J H van Tongeren
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

View more
  8 in total

1.  Regulation of T-cell activation in the lung: isolated lung T cells exhibit surface phenotypic characteristics of recent activation including down-modulated T-cell receptors, but are locked into the G0/G1 phase of the cell cycle.

Authors:  D Strickland; U R Kees; P G Holt
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  T-cell receptor sequencing reveals the clonal diversity and overlap of colonic effector and FOXP3+ T cells in ulcerative colitis.

Authors:  James Lord; Janice Chen; Richard C Thirlby; Anna M Sherwood; Christopher S Carlson
Journal:  Inflamm Bowel Dis       Date:  2015-01       Impact factor: 5.325

3.  Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease.

Authors:  F Autschbach; G Schürmann; L Qiao; H Merz; R Wallich; S C Meuer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes.

Authors:  N Watanabe; A Hizuta; N Tanaka; K Orita
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

5.  Cytotoxic activity of V beta 8+ T cells in Crohn's disease: the role of bacterial superantigens.

Authors:  M E Baca-Estrada; D K Wong; K Croitoru
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

6.  Apoptosis and inflammation: role of adipokines in inflammatory bowel disease.

Authors:  Venkatesh Ponemone; Ali Keshavarzian; Marc I Brand; Theodore Saclarides; Herand Abcarian; Robert J Cabay; Emma Fletcher; Bianca Larsen; Larry J Durstine; Giamila Fantuzzi; Raja Fayad
Journal:  Clin Transl Gastroenterol       Date:  2010-10-21       Impact factor: 4.488

7.  Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®.

Authors:  Anne-Kristin Heninger; Sabine Wentrup; Mohammed Al-Saeedi; Serin Schiessling; Thomas Giese; Florian Wartha; Stefan Meuer; Jutta Schröder-Braunstein
Journal:  Immun Inflamm Dis       Date:  2014-11-03

8.  Human monocytes downregulate innate response receptors following exposure to the microbial metabolite n-butyrate.

Authors:  Felix Lasitschka; Thomas Giese; Marco Paparella; Stefan R Kurzhals; Guido Wabnitz; Katrin Jacob; Judith Gras; Konrad A Bode; Anne-Kristin Heninger; Timea Sziskzai; Yvonne Samstag; Cornelia Leszinski; Bettina Jocher; Mohammed Al-Saeedi; Stefan C Meuer; Jutta Schröder-Braunstein
Journal:  Immun Inflamm Dis       Date:  2017-07-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.